Player FM ऐप के साथ ऑफ़लाइन जाएं!
Jul 19 2024 This Week in Cardiology
Manage episode 429719844 series 2794872
Vulnerable plaque and scientific method; industry payments to trainees; tirzepatide or semaglutide; trial interpretation; and PFA are the topics John Mandrola, MD, covers in today’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Non-invasive Imaging for Vulnerable Plaque
PET Imaging Finds Vulnerable Plaques That Cause MI
https://www.medscape.com/viewarticle/pet-imaging-finds-vulnerable-plaques-cause-mi-2024a1000cm2
- JACC paper https://doi.org/10.1016/j.jacc.2024.03.419
- Original JAMA-Card paper https://jamanetwork.com/journals/jamacardiology/fullarticle/2806690
II. Industry Payments to Fellows
- JAMA Network Letter https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2821267
III. GLP-1a Class Effect?
Semaglutide Significantly Improves Chronic Kidney Disease
Mounjaro Beats Ozempic, So Why Isn’t It More Popular?
https://www.medscape.com/viewarticle/mounjaro-beats-ozempic-so-why-isnt-it-more-popular-2024a1000ckd
- JAMA-Internal Medicine: Semaglutide vs Tirzepatide https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080
- SELECT trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
- FLOW trial https://www.nejm.org/doi/full/10.1056/NEJMoa2403347
- SURPASS-CVOT – Rationale https://doi.org/10.1016/j.ahj.2023.09.007
IV. Colchicine and Trial Interpretation in the Lancet
V. PFA
Pulsed Field Ablation for AF: Are US Electrophysiologists Too Easily Impressed?
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
326 एपिसोडस
Manage episode 429719844 series 2794872
Vulnerable plaque and scientific method; industry payments to trainees; tirzepatide or semaglutide; trial interpretation; and PFA are the topics John Mandrola, MD, covers in today’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Non-invasive Imaging for Vulnerable Plaque
PET Imaging Finds Vulnerable Plaques That Cause MI
https://www.medscape.com/viewarticle/pet-imaging-finds-vulnerable-plaques-cause-mi-2024a1000cm2
- JACC paper https://doi.org/10.1016/j.jacc.2024.03.419
- Original JAMA-Card paper https://jamanetwork.com/journals/jamacardiology/fullarticle/2806690
II. Industry Payments to Fellows
- JAMA Network Letter https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2821267
III. GLP-1a Class Effect?
Semaglutide Significantly Improves Chronic Kidney Disease
Mounjaro Beats Ozempic, So Why Isn’t It More Popular?
https://www.medscape.com/viewarticle/mounjaro-beats-ozempic-so-why-isnt-it-more-popular-2024a1000ckd
- JAMA-Internal Medicine: Semaglutide vs Tirzepatide https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080
- SELECT trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
- FLOW trial https://www.nejm.org/doi/full/10.1056/NEJMoa2403347
- SURPASS-CVOT – Rationale https://doi.org/10.1016/j.ahj.2023.09.007
IV. Colchicine and Trial Interpretation in the Lancet
V. PFA
Pulsed Field Ablation for AF: Are US Electrophysiologists Too Easily Impressed?
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
326 एपिसोडस
Wszystkie odcinki
×प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।